- Home
- GNLX vs CHMI Comparison
GNLX vs CHMI Comparison
Compare GNLX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | CHMI |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 83.3M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GNLX | CHMI |
|---|---|---|
| Price | $4.12 | $2.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $19.75 | $2.75 |
| AVG Volume (30 Days) | 187.8K | ★ 253.0K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 15.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $40,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.73 |
| P/E Ratio | ★ N/A | $135.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $2.17 |
| 52 Week High | $8.54 | $3.68 |
Technical Indicators
Market Signals| Indicator | GNLX | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 33.52 | 63.60 |
| Support Level | $4.37 | $2.47 |
| Resistance Level | $4.75 | $2.60 |
| Average True Range (ATR) | 0.41 | 0.07 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 5.82 | 93.33 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.